Claims for Patent: 8,058,052

Summary for Patent: 8,058,052

Title:	Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidse M
Abstract:	The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s):	Ryan; James W (Augusta, GA)
Assignee:	Ryogen LLC (Suffern, NY)
Application Number:	12/795,909
Patent Claims:	1. An isolated genomic nucleic acid molecule, said nucleic acid molecule obtainable from human chromosome 12q13-q15 region consisting of a nucleotide sequence at least 99% identical to a sequence selected from the group consisting of: (a) a nucleic acid molecule of SEQ ID NO:3; (b) a fragment of (a) that comprises nucleotides 16641-93041 of SEQ ID NO:3 which encodes a polypeptide that has Carboxypeptidase M activity depicted in SEQ ID NO: 1 and (c) the full complement of (a) or (b). 2. A nucleic acid construct comprising the nucleic acid molecule of claim 1. 3. An expression vector comprising the nucleic acid molecule of claim 1. 4. A recombinant host cell comprising the nucleic acid molecule of claim 1. 5. A method for obtaining human carboxypeptidase M comprising: (a) culturing the recombinant host cell of claim 4 under conditions that provide for the expression of said polypeptide and (b) recovering said expressed polypeptide. 6. A composition comprising the nucleic acid molecule of claim 1 and a carrier or diluent. 7. A kit comprising the nucleic acid molecule of claim 1. 8. A solid support comprising the nucleic acid molecule of claim 1. 9. The solid support of claim 8, wherein said solid support is a microarray. 10. A method for modulating levels of human carboxypeptidase M in a subject in need thereof comprising administering to said subject an amount of the nucleic acid molecule of claim 1 effective to modulate said human carboxypeptidase M levels. 11. A method for detecting the presence of the nucleic acid molecule of claim 1 in a sample, comprising contacting the sample with a nucleic acid molecule probe comprising at least 20 contiguous nucleotides that hybridizes to said nucleic acid molecule under high stringency hybridization conditions corresponding to the highest temperature of 65.degree. C. e.g., 50% formamide, 5.times. or 6.times.SSC and determining whether the nucleic acid molecule probe binds to said nucleic acid molecule in the sample. 12. An isolated nucleic acid molecule consisting of a fragment of a non-coding region of the nucleic acid molecule of claim 1, wherein said non-coding region is selected from the group consisting of a 5'-noncoding region shown in sequence segment 1-16440 of SEQ ID NO:3, a 3'-non coding region shown in sequence segment 93042-99680 of SEQ ID NO:3 and an intron region shown in sequence segments, 16797-63584, 63687-77521, 77693-79076, 79263-79981, 80153-82428, 82582-90405, 90556-92798 of SEQ ID NO:3, wherein said fragment is at least 20 nucleotides in length, wherein said noncoding fragment is at least 20 nucleotides in length or a full complement of said isolated nucleic acid molecule. 13. An isolated nucleic acid molecule consisting of a sequence segment of a nucleic acid molecule of claim 1, wherein said segment is at least 20 nucleotides in length consisting of a contiguous coding and non-coding nucleic acid sequence of SEQ ID NO:3. 14. A kit comprising the nucleic acid molecule of claim 12. 15. A solid support comprising the nucleic acid molecule of claim 12. 16. The solid support of claim 12 wherein said support is a microarray. 17. A microarray comprising a plurality of the nucleic acid molecules of claim 12. 18. The microarray of claim 17 wherein said microarray further comprises a nucleic acid molecule encoding Carboxypeptidase M, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides. 19. The microarray of claim 18 wherein said microarray further comprises a nucleic acid molecule encoding Carboxypeptidase M, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides. 20. A method for detecting the presence of a nucleic acid sequence of SEQ ID NO:3 or its fully complementary sequence in a sample, said method comprising contacting the sample with the nucleic acid molecule of claim 12 and determining whether the nucleic acid molecule binds to said nucleic acid sequence in the sample. 21. A kit comprising the nucleic acid molecule of claim 13. 22. A solid support comprising at least one nucleic acid molecule of claim 13. 23. The solid support of claim 22, wherein said solid support is a microarray. 24. A microarray comprising a plurality of the nucleic acid molecules of claim 13. 25. The microarray of claim 24, wherein said microarray further comprises a nucleic acid molecule encoding Carboxypeptidase M, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides. 26. A method for detecting the presence of a nucleic acid sequence of SEQ ID NO:3 or its fully complementary sequence in a sample, said method comprising contacting the sample with the nucleic acid molecule of claim 13 and determining whether the nucleic acid molecule binds to said nucleic acid sequence in the sample. 27. A microarray comprising a plurality of the nucleic acid molecules of claim 1. 28. The microarray of claim 27 wherein said microarray further comprises a nucleic acid molecule encoding Carboxypeptidase M, complementary sequence thereof or a portion of said nucleic acid molecule containing at least 20 contiguous nucleotides.

Details for Patent 8,058,052

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2023-06-27
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2023-06-27
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2023-06-27